-
AAPP 2024 Schedule
Enjoy browsing through all that the AAPP 2024 Annual Meeting has to offer!
Customize your schedule by bookmarking sessions of interest using the bookmark () buttons. Then, click the button below to only show your bookmarks.
Sunday, April 7, 2024
-
-
-
Industry Symposium With ACPE Credit
Not So Positive: Treating the Negative and Cognitive Symptoms of Schizophrenia
Supported by Boehringer Ingelheim ACPE Free Public Registration
Not So Positive: Treating the Negative and Cognitive Symptoms of Schizophrenia
Supported by Boehringer Ingelheim ACPE Free Public Registration
Andrew J. Cutler, MD
National A
-
-
-
Transforming Mental Health Systems: Lessons from the Global South
ACPE
Vikram Patel, MBBS, PhD
ACPE #: 0284-0000-24-014-L99-P (Knowledge) (1.00 hour)
International
-
-
Evidence-based Management of Borderline Personality Disorder
ACPE
BCPP
Katharine "Kaz" Joyer Nelson, MD, DFAPA
ACPE #: 0284-0000-24-015-L01-P (Application) (1.00 hour)
International
-
-
-
Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders
ACPE
BCPP
Tiffany R Buckley, PharmD, BCPS, BCPP
ACPE #: 0284-0000-24-016-L01-P (Application) (1.00 hour)
International
-
-
-
Monday, April 8, 2024
-
-
-
-
Industry Showcase
A Focused Approach: Targeting Muscarinic Receptors in Schizophrenia
Supported by Karuna Therapeutics Free Public Registration
A Focused Approach: Targeting Muscarinic Receptors in Schizophrenia
Supported by Karuna Therapeutics Free Public Registration
José Rey, MS, PharmD, BCPP
National A
-
-
-
-
-
-
Integrating Contraceptive Care in Psychiatry: Best Practices
ACPE
Veronica Vernon, PharmD, BCPS, BCACP, MSCP
ACPE #: 0284-0000-24-018-L01-P (Knowledge) (1.25 hours)
International
-
-
Insomnia: Treatment Resistance and Special Populations
ACPE
Megan Maroney, PharmD, BCPP
ACPE #: 0284-0000-24-023-L01-P (Knowledge) (1.25 hours)
International
-
-
Industry Symposium With ACPE Credit
Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Andrew J. Cutler, MD
National A
-
The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics
ACPE
BCPP
Chelsea Di Polito, PharmD, BCPP
ACPE #: 0284-0000-24-020-L04-P (Application) (1.00 hour)
IB II-III
-
Anticholinergic Deprescribing: What We Don’t Know
ACPE
Noll L. Campbell, PharmD, MS
ACPE #: 0284-0000-24-019-L01-P (Knowledge) (1.00 hour)
IB I
-
Addressing Ambivalence and Non-Adherence to Mental Health Treatment
ACPE
BCPP
Russell E. Spieth, MEd, PhD
ACPE #: 0284-0000-24-022-L99-P (Application) (1.00 hour)
IB II-III
-
Management of Clozapine-Resistant Schizophrenia
ACPE
Megan J. Ehret, PharmD, MS, BCPP
ACPE #: 0284-0000-24-028-L01-P (Knowledge) (1.00 hour)
IB I
-
-
Social Determinants of Health in the Treatment of Depression
ACPE
Shari N. Allen, PharmD, BCPP
ACPE #: 0284-0000-24-021-L01-P (Knowledge) (1.00 hour)
IB I
-
Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management
ACPE
BCPP
Kristen Ward, PharmD, BCPP
ACPE #: 0284-0000-24-024-L01-P (Application) (1.00 hour)
IB II-III
-
-
Industry Showcase
Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond
Supported by Saladax Biomedical Free Public Registration
Practical Learnings and Knowledge When Implementing Rapid TDM Blood Levels: A Focus on Clozapine and Beyond
Supported by Saladax Biomedical Free Public Registration
Speaker: Georgios Schoretsanitis, MD, PhD; Moderator: Megan Ehret, PharmD, MS, BCPP
National A
-
Tuesday, April 9, 2024
-
-
-
-
Industry Showcase
UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia
Supported by Teva Pharmaceutical Free Public Registration
UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia
Supported by Teva Pharmaceutical Free Public Registration
Ilan Melnick, MD
National A
-
-
-
-
-
Psychedelics: Ethics and Real World Applications
ACPE
Greg A. Fonzo, Ph.D.
ACPE #: 0284-0000-24-025-L01-P (Knowledge) (1.25 hours)
International
-
-
Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor
ACPE
Julie Cerel, PhD
ACPE #: 0284-0000-24-026-L99-P (Knowledge) (1.25 hours)
International
-
-
Industry Symposium With ACPE Credit
A New Script: Implementing Prescription Digital Therapeutics into Practice
Supported by Boehringer Ingelheim ACPE Free Public Registration
A New Script: Implementing Prescription Digital Therapeutics into Practice
Supported by Boehringer Ingelheim ACPE Free Public Registration
Kari Franson, PharmD, PhD, BCPP
National A
-
Clinical Pearls 1
ACPE
Shari N. Allen, PharmD, BCPP; Ahmaya Mustafa, PharmD, BCPS, BCPP; Audrey Abelleira, PharmD, BCPS, BCPP
ACPE #: 0284-0000-24-031-L04-P (Knowledge) (1.00 hour)
IB II
-
Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES)
ACPE
Austin De La Cruz, PharmD, BCPP
ACPE #: 0284-0000-24-029-L01-P (Knowledge) (1.00 hour)
IB III
-
Comprehensive Management of Psychiatric Medication Overdose
ACPE
Nena Bowman, PharmD, DABAT
ACPE #: 0284-0000-24-027-L01-P (Knowledge) (1.00 hour)
IB I
-
RLS Management and Psychiatric Comorbidity Considerations
ACPE
Arthur Walters, MD
ACPE #: 0284-0000-24-032-L01-P (Knowledge) (1.00 hour)
IB III
-
Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom)
ACPE
Steven W. Shoyer, PharmD, BCPP
ACPE #: 0284-0000-24-030-L01-P (Knowledge) (1.00 hour)
IB I
-
Clinical Pearls 2
ACPE
Ericka Crouse, PharmD, BCPP, BCGP; Ashley Maister, PharmD, BCPP; Christine Rarrick, PharmD, MBA, BCPS, BCPP
ACPE #: 0284-0000-24-033-L01-P (Knowledge) (1.00 hour)
IB II
-
-
Wednesday, April 10, 2024
-
-
-
-
-
Palliative Psychiatry for Severe, Persistent Mental Illness
ACPE
Diana V. Punko, MD, MS
ACPE #: 0284-0000-24-034-L01-P (Knowledge) (1.00 hour)
International
-
Gun Violence: Impact on Mental Health
ACPE
Howard Pinderhughes, PhD
ACPE #: 0284-0000-24-035-L99-P (Knowledge) (1.00 hour)
International
-
Psychiatric and Neurologic Medication Pipeline
ACPE
Stephen R. Saklad, PharmD, BCPP
ACPE #: 0284-0000-24-036-L01-P (Knowledge) (1.00 hour)
International